130
Participants
Start Date
October 22, 2019
Primary Completion Date
October 2, 2023
Study Completion Date
January 14, 2025
Lenvatinib
Lenvatinib 4 mg or 10 mg capsules at a total daily dose of 20 mg taken by mouth once per day.
Pembrolizumab
Pembrolizumab 200 mg IV infusion given on Day 1 of each cycle.
Paclitaxel
Paclitaxel 175 mg/m\^2 IV infusion given on Day 1 of each cycle.
Carboplatin
Carboplatin 10 mg/mL IV infusion at a total dose of are-under-the-curve (AUC) 6 (per Calvert's formula) given on Day 1 of each cycle.
Beijing Obstetrics and Gynecology Hospital Capital Medical University ( Site 2505), Beijing
Peking Union Medical College Hospital ( Site 2501), Beijing
Beijing Cancer Hospital ( Site 2504), Beijing
The First Hospital Of Jilin University ( Site 2518), Changchun
Harbin Medical University Cancer Hospital ( Site 2520), Harbin
Fudan University Shanghai Cancer Center ( Site 2500), Shanghai
Obstetrics and Gynecology Hosp. Fudan University ( Site 2503), Shanghai
Shanghai First Maternity and Infant Hospital ( Site 2524), Shanghai
Nanjing Maternity and Child Health Care Hospital ( Site 2508), Nanjing
Anhui Cancer Hospital-Gynecological Oncology ( Site 2509), Hefei
Women s Hospital School of Medicine Zhejiang University ( Site 2511), Hangzhou
Zhejiang Cancer Hospital ( Site 2506), Hangzhou
The First Affiliated hospital of Xiamen University-Obstetrics and gynecology department ( Site 2522), Xiamen
Chongqing Cancer Hospital ( Site 2513), Chongqing
Xiangya Hospital Central-South University ( Site 2512), Changsha
Hunan Cancer Hospital ( Site 2523), Changsha
Hubei Cancer Hospital ( Site 2510), Wuhan
The First Affiliated Hospital.Sun Yat-sen University ( Site 2507), Guangzhou
Guang Xi Tumour Hospital, Department of Chemotherapy ( Site 2517), Nanning
Jiangxi Maternal and Child Health Hospital ( Site 2519), Nanchang
The first affiliated Hospital of Xi an Jiaotong University ( Site 2502), Xi'an
The First Affiliated Hospital of Xinjiang Medical University ( Site 2515), Ürümqi
Eisai Inc.
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY